JA60 - Excessive Vomiting in Pregnancy: Complete ICD-11 Coding Guide
1. Introduction
Excessive vomiting in pregnancy, clinically known as hyperemesis gravidarum, represents a significant obstetric condition that transcends the common morning sickness experienced by many pregnant women. This condition is characterized by persistent and severe nausea and vomiting that can lead to dehydration, electrolyte imbalance, weight loss, and maternal-fetal nutritional compromise.
The clinical importance of this condition lies in its potential to cause serious complications for both mother and fetus. Unlike typical morning sickness that affects most pregnant women in the first trimester, excessive vomiting is incapacitating and requires medical intervention. This condition is one of the leading causes of hospitalization in the first trimester of pregnancy and may persist beyond this period in more severe cases.
From a public health perspective, excessive vomiting in pregnancy represents a significant challenge. It impacts the quality of life of pregnant women, may affect their work capacity, and in cases not treated appropriately, may result in maternal complications such as ketoacidosis, acute kidney injury, and venous thrombosis. For the fetus, the condition may be associated with low birth weight and, in extreme cases, premature delivery.
Correct coding using code JA60 is critical for various aspects of medical care. It enables appropriate epidemiological tracking, facilitates proper allocation of hospital resources, ensures correct reimbursement of services provided, and enables clinical research on effective treatments. Additionally, accurate documentation aids in continuity of care among different healthcare professionals and institutions.
2. Correct ICD-11 Code
Code: JA60
Description: Excessive vomiting in pregnancy
Parent category: Some specified maternal disorders predominantly related to pregnancy
This code is part of the chapter on conditions related to pregnancy, childbirth, and the puerperium in ICD-11, specifically within maternal complications that occur predominantly during gestation. Code JA60 was developed to capture cases that go beyond the mild and transient gastrointestinal symptoms common in early pregnancy.
The classification recognizes that this condition requires specific and differentiated medical attention. The code encompasses both cases requiring hospitalization and those managed on an outpatient basis, provided they meet the severity criteria that characterize excessive vomiting. The structure of ICD-11 allows greater specificity in clinical documentation, facilitating differentiation between common nausea and vomiting in pregnancy and pathological cases that require therapeutic intervention.
Appropriate use of this code ensures that health information systems can identify pregnant women at risk, monitor epidemiological trends, and evaluate the effectiveness of treatment protocols. It is essential that healthcare professionals understand not only when to use this code, but also its position within the broader classificatory structure of obstetric complications.
3. When to Use This Code
Code JA60 should be applied in specific clinical situations that characterize pathological excessive vomiting in pregnancy:
Scenario 1: Pregnant patient with dehydration and electrolyte imbalance A patient in the first trimester presents with multiple daily vomiting episodes (more than five episodes) for at least three consecutive days, with inability to retain fluids or food. Laboratory tests demonstrate ketonuria, elevated urea and creatinine, and electrolyte alterations such as hypokalemia. The patient presents with weight loss greater than 5% of pre-pregnancy weight. This is a classic case for application of code JA60.
Scenario 2: Hospitalization for intractable vomiting Pregnant woman at 8 weeks of gestation who requires hospital admission due to inability to maintain adequate oral hydration. Requires intravenous hydration, electrolyte replacement, and parenteral antiemetic medication. The severity of symptoms prevents her normal daily activities and represents risk to maternal and fetal health. Code JA60 is appropriate regardless of hospitalization duration.
Scenario 3: Persistent vomiting with ketosis Pregnant patient presents with intense nausea and vomiting accompanied by ketonuria detected on urinalysis or ketone reagent strip test. The presence of ketosis indicates prolonged fasting and inadequate carbohydrate metabolism, characterizing the severity of the condition. Even if managed on an outpatient basis with hydration and medication, code JA60 is appropriate.
Scenario 4: Vomiting with significant nutritional impact Pregnant woman who presents with documented and progressive weight loss associated with frequent vomiting, with inability to maintain adequate caloric intake for a prolonged period. Nutritional assessment demonstrates deficiencies and risk of fetal development compromise. Code JA60 adequately captures this clinical presentation.
Scenario 5: Recurrence in current pregnancy after initial improvement Patient who had presented with improvement of emetic symptoms early in pregnancy but develops severe recurrence of vomiting in the second trimester, requiring reintervention with potent antiemetic medication and close clinical monitoring. Code JA60 remains applicable throughout pregnancy when severity criteria are present.
Scenario 6: Complications secondary to vomiting Pregnant woman develops esophagitis, esophageal rupture (Mallory-Weiss syndrome), or other direct complications from repeated vomiting episodes. Even when these complications require specific additional codes, code JA60 should be used to document the underlying primary condition.
4. When NOT to Use This Code
It is essential to recognize situations where code JA60 is not appropriate, avoiding incorrect coding:
Mild nausea and vomiting in the first trimester: Most pregnant women experience some degree of occasional nausea and vomiting in early pregnancy. When these symptoms are mild, do not prevent adequate feeding, do not cause dehydration or weight loss, and do not require medical intervention beyond dietary guidance and possibly mild antiemetics, they do not qualify as excessive vomiting. These cases represent normal physiological manifestations of pregnancy.
Vomiting related to other medical conditions: When vomiting is secondary to acute gastroenteritis, appendicitis, pancreatitis, peptic ulcer, intestinal obstruction, or other gastrointestinal conditions not specifically related to pregnancy, the primary code should reflect the causative condition. The fact that the patient is pregnant does not automatically transform any episode of vomiting into hyperemesis gravidarum.
Vomiting from specific metabolic causes: When vomiting is a manifestation of hyperthyroidism, decompensated diabetes, adrenal insufficiency, or other endocrinopathies, the appropriate code is that of the primary endocrine condition. Even in pregnant women, it is essential to identify the specific etiology.
Vomiting from neurological causes: Severe migraine, brain tumors, meningitis, or other neurological conditions that cause vomiting should be coded according to the specific neurological diagnosis, not as excessive vomiting of pregnancy.
Poisonings and adverse drug effects: Vomiting resulting from food poisoning, use of specific medications, or exposure to toxins should be coded according to the specific cause, using poisoning or adverse reaction codes when appropriate.
5. Step-by-Step Coding Process
Step 1: Assess Diagnostic Criteria
Confirmation of the diagnosis of excessive vomiting in pregnancy requires systematic evaluation of multiple criteria. First, establish the presence of viable pregnancy through positive human chorionic gonadotropin test and, when possible, ultrasound confirming intrauterine gestation. Gestational age is relevant, as the condition is more common in the first trimester, although it may occur later.
Evaluate the frequency and severity of vomiting. Document how many episodes occur daily and for how many days the condition has persisted. Excessive vomiting typically involves multiple daily episodes that prevent adequate feeding and hydration. Investigate whether there are periods of the day with greater symptom intensity and whether there are identifiable triggering factors.
Examine clinical signs of dehydration: dry mucous membranes, reduced skin turgor, tachycardia, orthostatic hypotension, and oliguria. These objective findings are crucial for establishing the severity of the condition. Document current weight and compare with pre-gestational weight or previous records to quantify weight loss.
Request essential laboratory tests: complete blood count, renal function (urea and creatinine), electrolytes (sodium, potassium, chloride), liver function, and urinalysis including ketone screening. The presence of ketonuria is an important marker of prolonged fasting and inadequate metabolism. Electrolyte alterations and elevated urea/creatinine indicate significant dehydration.
Standardized assessment instruments, such as the PUQE index (Pregnancy-Unique Quantification of Emesis), may assist in objective quantification of symptom severity, although they are not mandatory for coding.
Step 2: Verify Specifiers
ICD-11 allows additional specification of relevant clinical characteristics. Assess the severity of the condition: mild cases may be managed on an outpatient basis with oral hydration and antiemetic medication, while moderate to severe cases require hospitalization for intravenous hydration and parenteral medication.
Document symptom duration. Excessive vomiting may be classified as acute (less than 4 weeks duration) or prolonged (persisting beyond the first trimester). This distinction has prognostic and therapeutic implications.
Identify associated complications that may require additional codes: specific nutritional deficiencies (thiamine, vitamin B12), hepatic alterations (transaminase elevation), esophageal complications (esophagitis, Mallory-Weiss syndrome), or neurological complications (Wernicke encephalopathy in severe untreated cases).
Record response to initial treatment. Cases refractory to conventional therapeutic measures may require more aggressive approaches and represent a subgroup of greater severity.
Step 3: Differentiate from Other Codes
JA61 - Venous complications in pregnancy: This code is used for deep vein thrombosis, superficial thrombophlebitis, pulmonary embolism, and other complications of the venous system that occur during pregnancy. The fundamental difference is that JA61 involves the venous vascular system, whereas JA60 refers to gastrointestinal symptoms. Although severe dehydration from excessive vomiting may increase the risk of venous thrombosis, if a pregnant woman develops both conditions, both codes should be used, with the venous complication representing a secondary consequence.
JA62 - Infections of the genitourinary tract in pregnancy: This code captures bacterial infections of the urinary or genital system during pregnancy, such as cystitis, pyelonephritis, or vaginal infections. The distinction is clear: JA62 involves infectious processes confirmed by laboratory tests (positive urine culture, microscopic examination demonstrating pyuria), whereas JA60 is a non-infectious condition characterized by emetic symptoms. Occasionally, dehydration from excessive vomiting may predispose to urinary tract infection, a situation in which both codes would be appropriate.
JA63 - Gestational diabetes: This condition is characterized by glucose intolerance that arises or is diagnosed for the first time during pregnancy, typically identified through screening tests in the second trimester. The main difference is that JA63 is an endocrine metabolic disorder, whereas JA60 is a gastrointestinal condition. Although poorly controlled gestational diabetes may occasionally cause nausea, vomiting is not the primary manifestation. The two conditions may coexist in the same pregnant woman, but they are distinct entities that require separate codes.
Step 4: Required Documentation
Adequate documentation should include a checklist of mandatory information to justify JA60 coding:
Essential clinical information: Date of symptom onset, daily frequency of vomiting episodes, ability to retain food and liquids, quantified weight loss, presence of signs of dehydration on physical examination, and gestational age at presentation.
Laboratory data: Results of blood tests demonstrating renal function, electrolytes, complete blood count, and liver function. Results of urinalysis including ketone screening. Documentation of alterations that confirm the severity of the condition.
Therapeutic interventions: Record of antiemetic medications prescribed, need for intravenous hydration, duration of hospitalization if applicable, and response to instituted treatment.
Exclusion of differential diagnoses: Documentation that other causes of vomiting were considered and excluded through clinical history, physical examination, and appropriate investigations.
Functional impact: Description of how symptoms affect the patient's daily activities, her ability to work, and her overall quality of life.
Record appropriately using precise medical terminology, avoiding vague descriptions. Note specific dates, numerical values of tests, and objective quantifications whenever possible. This detailed documentation not only justifies the coding but also facilitates continuity of care and may be crucial for medicolegal purposes.
6. Complete Practical Example
Clinical Case
Marina, 28 years old, primigravida, presents to the emergency department at 9 weeks of gestation. She reports that approximately 2 weeks ago she began experiencing intense nausea and frequent vomiting. Initially, the symptoms were morning-related and occasional, but progressively intensified. Over the last 5 days, she vomits between 8 to 10 times daily, being unable to retain any solid or liquid food, including water.
Marina reports feeling extremely weak, dizzy upon standing, and notes that her urine is darker and in smaller quantities. She has lost 4.5 kg since the beginning of pregnancy (pre-pregnancy weight of 62 kg). She tried home remedies such as ginger and dietary changes without success. Her physician had prescribed oral antiemetic 3 days ago, but she cannot retain it due to vomiting.
On physical examination: dehydrated patient, dry mucous membranes, reduced skin turgor, heart rate of 105 bpm, blood pressure 95/60 mmHg (usual 110/70 mmHg). Abdomen without masses or significant pain on palpation. Obstetric examination: uterus compatible with gestational age, fetal heart sounds present on ultrasound.
Laboratory tests requested reveal: urea 58 mg/dL (normal up to 40), creatinine 1.3 mg/dL (normal 0.6-1.2), sodium 148 mEq/L (normal 135-145), potassium 3.1 mEq/L (normal 3.5-5.0), hemoglobin 14.8 g/dL with hematocrit of 44% (suggesting hemoconcentration). Urinalysis: specific gravity 1.030, ketones 3+, absence of leukocytes or bacteria.
Step-by-Step Coding
Criteria analysis:
Confirmed pregnancy criterion: Present - 9-week gestation confirmed by ultrasound with fetal heart sounds present.
Excessive vomiting criterion: Present - 8 to 10 episodes daily for 5 consecutive days with complete inability to retain food or liquids.
Dehydration criterion: Present - evident clinical signs (dry mucous membranes, reduced turgor, tachycardia, hypotension) confirmed by laboratory alterations (elevation of urea/creatinine, hemoconcentration, increased urine specific gravity).
Metabolic disorder criterion: Present - ketonuria 3+ indicating prolonged fasting and inadequate carbohydrate metabolism.
Weight loss criterion: Present - loss of 4.5 kg represents 7.3% of pre-pregnancy weight, exceeding the 5% threshold frequently used.
Electrolyte imbalance criterion: Present - hypokalemia (3.1 mEq/L) and hypernatremia (148 mEq/L) secondary to vomiting and dehydration.
Code chosen: JA60 - Excessive vomiting in pregnancy
Complete justification:
Marina's case fully meets the diagnostic criteria for excessive vomiting in pregnancy. The severity of symptoms, documented by vomiting frequency, inability to maintain oral hydration, clinical and laboratory signs of dehydration, presence of ketonuria and significant weight loss, clearly characterizes this condition beyond common nausea and vomiting of pregnancy.
The absence of fever, leukocytosis, or findings suggesting infection excludes gastroenteritis or other infectious causes. The absence of significant abdominal pain and normal abdominal examination findings make surgical causes such as appendicitis or intestinal obstruction unlikely. The classic presentation in the first trimester and the temporal progression of symptoms are consistent with hyperemesis gravidarum.
Applicable complementary codes:
E87.6 - Hypokalemia: Documented laboratorially and clinically relevant, requiring specific replacement.
E86 - Volume depletion: Severe dehydration confirmed clinically and laboratorially.
Management and follow-up:
Marina was admitted for intravenous hydration with saline solution and potassium replacement, administration of parenteral antiemetics (ondansetron and metoclopramide), and thiamine supplementation to prevent Wernicke encephalopathy. After 48 hours of treatment, she showed significant improvement, being able to tolerate liquids and light foods. She was discharged with dietary guidance, oral antiemetic medication, and close outpatient follow-up. The code JA60 was used as the principal diagnosis at admission.
7. Related Codes and Differentiation
Within the Same Category
JA61: Venous complications in pregnancy
When to use JA61: This code is appropriate when the pregnant woman develops deep vein thrombosis, superficial thrombophlebitis, pulmonary embolism, or other complications of the venous system during pregnancy. Typical clinical presentation includes pain, edema, and warmth in the lower limb (for DVT), or dyspnea, chest pain, and tachycardia (for pulmonary embolism). Diagnosis is confirmed by imaging studies such as Doppler ultrasound or angiographic computed tomography.
Main difference vs. JA60: JA61 involves the venous vascular system with thrombus formation or venous inflammation, whereas JA60 is a gastrointestinal condition characterized by vomiting. The pathophysiology is completely different. However, there is a potential connection: severe dehydration from excessive vomiting increases blood viscosity and may predispose to thromboembolic events. In this scenario, both codes would be used, with JA60 as the primary condition and JA61 as a secondary complication.
JA62: Genitourinary tract infections in pregnancy
When to use JA62: This code captures bacterial infections of the urinary or genital system that occur during pregnancy. It includes cystitis (bladder infection), pyelonephritis (kidney infection), significant asymptomatic bacteriuria, and vaginal or cervical infections. Diagnosis requires laboratory confirmation through positive urine culture (usually >100,000 colonies/mL), urinalysis demonstrating pyuria, or positive vaginal/cervical cultures.
Main difference vs. JA60: JA62 is an infectious condition caused by bacterial pathogens, whereas JA60 is non-infectious and related to hormonal and metabolic changes of pregnancy. Clinical presentation differs: urinary tract infections present with dysuria, polyuria, suprapubic or lower back pain, and frequently fever (especially in pyelonephritis), while excessive vomiting manifests primarily with emetic and gastrointestinal symptoms. Occasionally, dehydration from excessive vomiting may predispose to urinary tract infection through urinary stasis and urine concentration, a situation in which both codes would be appropriate.
JA63: Gestational diabetes
When to use JA63: This code is used when there is a diagnosis of glucose intolerance that arises or is identified for the first time during pregnancy. Diagnosis is established through standardized screening tests, typically performed between 24-28 weeks of gestation, although it may be diagnosed earlier in high-risk pregnant women. It includes oral glucose tolerance test with blood glucose values above established cutoff points.
Main difference vs. JA60: JA63 is an endocrine metabolic disorder characterized by hyperglycemia and insulin resistance, whereas JA60 is a gastrointestinal condition with vomiting as the primary manifestation. The timing of presentation also differs: gestational diabetes is typically diagnosed in the second trimester, whereas excessive vomiting is more common in the first trimester. Clinical manifestations are distinct: gestational diabetes is often asymptomatic and detected by screening, whereas excessive vomiting presents with evident and incapacitating symptoms. Both conditions may coexist in the same pregnant woman, but they are independent entities that require separate coding.
Differential Diagnoses
Acute gastroenteritis: Characterized by vomiting, diarrhea, abdominal pain, and frequently fever. It differs from JA60 by the presence of diarrhea (generally absent in excessive vomiting of pregnancy), self-limited nature (resolution in 24-72 hours), and possible exposure to contaminated food or contact with sick individuals. Laboratory tests may show leukocytosis if bacterial infection.
Appendicitis in pregnancy: Presents with progressive abdominal pain, initially periumbilical migrating to the right iliac fossa (although location may vary with gestational age), fever, leukocytosis, and signs of peritoneal irritation. It differs from JA60 by the predominance of pain over vomiting and specific findings on physical examination and imaging.
Gastroesophageal reflux disease: Common in pregnancy, characterized by heartburn, regurgitation, and retrosternal discomfort, especially after meals. It differs from JA60 by the absence of excessive vomiting, dehydration, or significant weight loss.
8. Differences with ICD-10
In ICD-10, excessive vomiting in pregnancy was coded primarily as O21, with subdivisions: O21.0 (mild hyperemesis gravidarum), O21.1 (hyperemesis gravidarum with metabolic disturbance), O21.2 (late vomiting of pregnancy), and O21.9 (vomiting in pregnancy, unspecified). This structure allowed some specification of severity and timing.
The main change in ICD-11 with code JA60 is the simplification of the coding structure, consolidating the various subdivisions of ICD-10 into a single more comprehensive code. This change reflects a more pragmatic approach, recognizing that the distinction between subtypes is often arbitrary in clinical practice and that severity can be documented through additional specifiers when necessary.
ICD-11 also offers greater flexibility in documenting clinical features through the system of extensions and specifiers, allowing information about severity, duration, and complications to be added in a standardized manner without the need for multiple different primary codes.
The practical impact of these changes includes simplification of the coding process, reduction of errors related to choosing between similar subdivisions, and greater consistency in coding across different professionals and institutions. For health information systems, the transition requires adequate mapping of previous ICD-10 codes to the new JA60 code, ensuring continuity in epidemiological data and longitudinal studies.
Another significant difference is the clearer hierarchical structure in ICD-11, where JA60 is explicitly positioned within the category of specified maternal disorders predominantly related to pregnancy, facilitating navigation and understanding of the relationships between different obstetric conditions.
9. Frequently Asked Questions
How is the diagnosis of excessive vomiting in pregnancy made?
The diagnosis is primarily clinical, based on a history of frequent and persistent vomiting that prevents adequate feeding and hydration, associated with signs of dehydration and weight loss. There is no single definitive diagnostic test. The evaluation includes confirmation of pregnancy, quantification of the frequency and duration of vomiting, physical examination to detect signs of dehydration, and laboratory tests to assess renal function, electrolytes, and presence of ketones in the urine. Imaging studies such as ultrasound may be requested to confirm fetal viability and exclude molar pregnancy, which may be associated with more severe vomiting. It is essential to exclude other causes of vomiting through detailed history and appropriate investigations.
Is treatment available in public health systems?
Treatment for excessive vomiting in pregnancy is generally available in public health systems in most countries, as it involves relatively accessible measures. Management includes hydration (oral or intravenous, depending on severity), antiemetic medications (various options with different costs), electrolyte replacement, and vitamin supplementation, especially thiamine. Mild cases can be managed on an outpatient basis with dietary counseling and oral medication. Moderate to severe cases require hospitalization for intravenous hydration and parenteral medication. The availability of specific medications may vary between different health systems, but effective therapeutic options are generally accessible. Parenteral nutrition may be necessary in extremely rare and refractory cases, which may present availability challenges in some contexts.
How long does treatment last?
The duration of treatment varies significantly depending on the severity of the condition and individual response. Mild cases may respond to dietary measures and oral medication within a few days. Typical hospitalizations for moderate to severe cases last between 2 to 4 days, a time generally sufficient for rehydration, correction of electrolyte disturbances, and stabilization of the patient with effective antiemetic medication. However, symptoms frequently persist to varying degrees for several weeks. Most pregnant women experience significant improvement by the end of the first trimester (12-14 weeks), although some may have symptoms persisting into the second trimester or, rarely, throughout the pregnancy. Frequent outpatient follow-up is necessary after hospital discharge to monitor weight, hydration, and adjust medications. Treatment is considered successful when the pregnant woman is able to maintain adequate hydration and nutrition, gain appropriate weight, and return to normal activities.
Can this code be used in medical certificates?
Yes, the code JA60 can and should be used in medical certificates when appropriate. Excessive vomiting in pregnancy frequently incapacitates the pregnant woman from her work activities, justifying work leave. Appropriate medical documentation, including the correct ICD-11 code, is essential for purposes of work and social security benefits. The certificate should specify the period of leave necessary, which may range from a few days to several weeks depending on severity. It is important that the physician objectively documents the symptoms, clinical and laboratory findings that justify work incapacity. In some cases, even after improvement sufficient for hospital discharge, the pregnant woman may require continued leave due to persistence of symptoms that, although not requiring hospitalization, prevent adequate performance of her professional duties.
Can excessive vomiting affect the baby?
When adequately treated, excessive vomiting in pregnancy generally does not cause permanent damage to the fetus. Studies demonstrate that most babies born to mothers who had hyperemesis gravidarum have normal development. However, severe untreated cases may be associated with low birth weight, premature delivery, and in extreme situations, intrauterine growth restriction. Severe and prolonged maternal dehydration can temporarily affect placental blood flow. Nutritional deficiencies, especially thiamine, can have serious consequences if not corrected. Therefore, it is crucial that pregnant women with excessive vomiting receive adequate and timely treatment. Regular prenatal follow-up allows monitoring of fetal growth through ultrasound and ensures that development is progressing normally. In most appropriately treated cases, fetal outcomes are excellent.
Is there a risk of recurrence in future pregnancies?
Pregnant women who experienced excessive vomiting in one pregnancy have an increased risk of recurrence in subsequent pregnancies. Studies suggest that the recurrence rate may reach 80% in some populations. However, the severity may vary between different pregnancies. Some women may have milder symptoms in subsequent pregnancies, while others may experience similar or greater severity. Factors that may influence the risk of recurrence include fetal sex (female pregnancies may be associated with more severe symptoms), multiple gestations (twins or more), and conditions such as gestational trophoblastic disease. For women with a history of excessive vomiting in a previous pregnancy, preconception planning is recommended with discussion of preventive strategies, early initiation of prophylactic antiemetic medication as soon as pregnancy is confirmed, and more frequent prenatal follow-up in the first trimester for rapid intervention should symptoms develop.
Which medications are safe during pregnancy for vomiting?
Several antiemetic medications are considered safe for use during pregnancy. Antihistamines such as doxylamine and meclizine are frequently used as first-line agents, with a well-established safety profile. Vitamin B6 (pyridoxine), alone or in combination with doxylamine, has demonstrated efficacy and safety. Dopamine receptor antagonists such as metoclopramide are widely used and considered safe. Serotonin receptor antagonists, particularly ondansetron, are effective for more severe cases, although there is debate about possible minimal risks that must be balanced against benefits. Corticosteroids may be considered in severe refractory cases, generally after the first trimester. Phenothiazines such as promethazine are also options. The choice of medication depends on the severity of symptoms, previous response to treatments, and individualized consideration of risks and benefits. It is essential that medications be prescribed by a healthcare professional familiar with the management of vomiting in pregnancy.
How to differentiate normal pregnancy vomiting from excessive vomiting?
The differentiation is based primarily on the severity, frequency, and impact of symptoms. Common nausea and vomiting in pregnancy ("morning sickness") affects most pregnant women, typically begins between 4-6 weeks of gestation, has mild to moderate intensity, frequently occurs in the morning but can happen at other times, and generally does not prevent adequate feeding throughout the day. The pregnant woman is able to maintain hydration, does not lose significant weight, and can continue her normal daily activities, although with some discomfort. Excessive vomiting, in contrast, is severe and persistent, occurs multiple times per day (frequently 5 or more episodes), prevents any oral feeding or hydration, causes significant weight loss (generally more than 5% of pre-pregnancy weight), results in dehydration with evident clinical signs, causes detectable ketonuria on urine examination, and incapacitates the pregnant woman from her normal activities. If there is doubt, medical evaluation is essential to determine the need for therapeutic intervention.
Keywords: ICD-11, JA60, excessive vomiting pregnancy, hyperemesis gravidarum, medical coding, obstetric complications, gestational dehydration, pregnancy nausea, first trimester, gestational ketonuria
External References
This article was prepared based on reliable scientific sources:
- 🌍 WHO ICD-11 - Excessive vomiting in pregnancy
- 🔬 PubMed Research on Excessive vomiting in pregnancy
- 🌍 WHO Health Topics
- 📊 Clinical Evidence: Excessive vomiting in pregnancy
- 📋 Ministry of Health - Brazil
- 📊 Cochrane Systematic Reviews
References verified on 2026-02-04